Fertilizers · Founded 1966 · www.mangalorechemicals.com · BSE 530011 · NSE MANGLR.CHEM · ISIN INE558B01017
No Notes Added Yet
1. Business Overview
Mangalore Chemicals & Fertilizers Ltd. (MCFL) is primarily engaged in the manufacturing, trading, and selling of fertilizers and industrial chemicals. Its core business revolves around producing a range of phosphatic and nitrogenous fertilizers, including Urea, Diammonium Phosphate (DAP), and various NPK complex fertilizers. The company also produces certain industrial products such as ammonium bicarbonate, sulphur, and sulphuric acid. MCFL's business model relies on converting raw materials (like natural gas for urea, imported phosphoric acid, and ammonia for DAP/complexes) into finished fertilizers, which are then sold primarily to farmers across South India. Revenue is generated from the sale of these products, with a significant portion of fertilizer sales being subject to government subsidy schemes in India.
2. Key Segments / Revenue Mix
The vast majority of MCFL's revenue is derived from its fertilizer segment.
Fertilizers: This segment includes the production and sale of Urea, DAP, MOP (Muriate of Potash, typically traded), and various NPK complex fertilizers. This forms the dominant portion of their top line.
Industrial Products: A smaller segment comprising products like ammonium bicarbonate, sulphuric acid, and other by-products.
Specific revenue contribution percentages for each fertilizer type or the industrial segment are not consistently disclosed, but fertilizers are the core and largest contributor.
3. Industry & Positioning
The Indian fertilizer industry is characterized by significant government intervention through subsidies, price controls, and distribution regulations, making it highly dependent on policy changes. It is also capital-intensive and reliant on imported raw materials (e.g., natural gas, rock phosphate, ammonia) and finished products (like MOP). MCFL is a mid-sized player within the Indian fertilizer landscape, with a strong regional presence, particularly in South India (Karnataka, Kerala, Tamil Nadu, Andhra Pradesh, Telangana). It competes with larger pan-India players like Coromandel International, Chambal Fertilizers, and public sector undertakings such as Rashtriya Chemicals & Fertilizers (RCF) and National Fertilizers Limited (NFL), as well as co-operatives like IFFCO and KRIBHCO. Its strategic location in Mangalore provides logistical advantages for raw material imports and distribution in its primary markets.
4. Competitive Advantage (Moat)
MCFL operates in a highly commoditized industry with limited strong competitive advantages. However, it possesses certain characteristics that provide some stability:
Established Infrastructure & Location: Its integrated manufacturing facility in Mangalore, a port city, offers a logistical advantage for importing key raw materials and distributing finished products efficiently across South India.
Brand Recognition: MCFL has an established brand name and distribution network in its operating regions, fostering customer loyalty among farmers.
High Entry Barriers: The fertilizer industry is capital-intensive and subject to stringent regulatory approvals, which limits new entrants.
Operational Integration: Some degree of integration in production of intermediate chemicals (e.g., sulphuric acid) for its phosphatic fertilizers.
5. Growth Drivers
Agricultural Growth & Food Demand: Increasing population and government focus on food security will continue to drive demand for fertilizers in India.
Favorable Monsoon: Good monsoons directly correlate with higher agricultural output and, consequently, increased fertilizer consumption.
Government Support & Policies: Continued government focus on supporting farmers and promoting balanced fertilization through subsidies and schemes can boost demand.
Operational Efficiency: Improvements in plant utilization, energy efficiency, and cost management can enhance profitability.
Product Mix Optimization: Shifting towards higher-margin complex fertilizers can improve overall profitability.
6. Risks
Regulatory & Subsidy Risk: High dependence on government subsidies; any adverse changes in subsidy policy (amount, timely disbursement, or calculation methodology) can severely impact profitability and working capital.
Raw Material Price Volatility: Significant exposure to volatile international prices of natural gas, ammonia, phosphoric acid, and MOP, which are largely imported.
Foreign Exchange Fluctuations: Vulnerability to currency depreciation due to high import content for raw materials.
Monsoon Dependence: Poor or erratic monsoons can lead to lower agricultural output and reduced fertilizer demand.
Environmental Regulations: Stricter environmental norms could lead to increased compliance costs or operational restrictions.
Intense Competition: Competition from domestic producers and imports can put pressure on pricing and margins.
Working Capital Management: Significant working capital requirements due to delays in subsidy realization from the government.
7. Management & Ownership
Mangalore Chemicals & Fertilizers Ltd. is part of the Adventz Group, a conglomerate with diversified business interests. Zuari Agro Chemicals Ltd. (also part of the Adventz Group) is the promoter and largest shareholder, holding a controlling stake. The company's management operates under the broader strategic direction of the Adventz Group. The promoter-led ownership structure ensures clear strategic direction and long-term vision for the company, aligning with group objectives in the agri-business sector.
8. Outlook
MCFL operates in an essential but highly regulated sector. The company's outlook is a balance between supportive long-term demand drivers for fertilizers in India and inherent risks. On the positive side, consistent demand for food, government emphasis on agricultural productivity, and the company's strong regional presence and established infrastructure provide a stable base. Good monsoons and timely, favorable government subsidy policies can significantly support its performance and financial health. However, the company faces substantial risks from volatile raw material prices, dependence on government subsidies with potential for delays in payments, and intense competition. Changes in global energy and commodity markets, as well as domestic policy shifts, will be critical determinants of its near-to-medium term prospects. Its ability to manage working capital, optimize its product mix, and enhance operational efficiencies will be key to navigating these challenges.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1164 | 958 | 1410 | 641 | 786 | 814 | 776 | 968 | 774 | 862 |
| Other Income | 11 | 7 | 10 | 11 | 13 | 6 | 5 | 7 | 18 | 7 |
| Total Income | 1175 | 965 | 1421 | 651 | 799 | 821 | 782 | 975 | 792 | 869 |
| Total Expenditure | 1036 | 842 | 1269 | 559 | 750 | 708 | 701 | 865 | 736 | 751 |
| Operating Profit | 139 | 124 | 152 | 92 | 49 | 112 | 81 | 110 | 55 | 118 |
| Interest | 31 | 30 | 28 | 23 | 23 | 25 | 20 | 16 | 15 | 17 |
| Depreciation | 17 | 17 | 17 | 18 | 19 | 19 | 19 | 19 | 19 | 18 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 92 | 76 | 106 | 51 | 7 | 68 | 41 | 75 | 22 | 83 |
| Provision for Tax | 24 | 27 | 39 | 18 | 2 | 24 | 15 | 18 | 6 | 21 |
| Profit After Tax | 68 | 49 | 68 | 33 | 5 | 44 | 26 | 57 | 16 | 62 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 68 | 49 | 68 | 33 | 5 | 44 | 26 | 57 | 16 | 62 |
| Adjusted Earnings Per Share | 5.7 | 4.2 | 5.7 | 2.8 | 0.4 | 3.7 | 2.2 | 4.8 | 1.4 | 5.2 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2577 | 2969 | 2479 | 2689 | 3074 | 2711 | 2144 | 2896 | 3642 | 3795 | 3332 | 3380 |
| Other Income | 11 | 15 | 31 | 44 | 12 | 23 | 33 | 24 | 31 | 41 | 37 | 37 |
| Total Income | 2588 | 2984 | 2510 | 2733 | 3086 | 2734 | 2177 | 2920 | 3672 | 3837 | 3369 | 3418 |
| Total Expenditure | 2415 | 2868 | 2328 | 2536 | 2886 | 2507 | 1944 | 2685 | 3332 | 3420 | 3010 | 3053 |
| Operating Profit | 173 | 116 | 182 | 196 | 200 | 227 | 233 | 235 | 340 | 417 | 359 | 364 |
| Interest | 126 | 115 | 116 | 84 | 111 | 111 | 77 | 49 | 104 | 105 | 76 | 68 |
| Depreciation | 29 | 32 | 35 | 37 | 39 | 45 | 50 | 51 | 60 | 72 | 76 | 75 |
| Exceptional Income / Expenses | 0 | -217 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 18 | -248 | 30 | 75 | 50 | 70 | 106 | 135 | 176 | 241 | 206 | 221 |
| Provision for Tax | -19 | -8 | 11 | 14 | 17 | 6 | 38 | 47 | 41 | 86 | 62 | 60 |
| Profit After Tax | 38 | -240 | 19 | 61 | 33 | 65 | 67 | 88 | 135 | 155 | 144 | 161 |
| Adjustments | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 38 | -242 | 19 | 61 | 33 | 65 | 67 | 88 | 135 | 155 | 144 | 161 |
| Adjusted Earnings Per Share | 3.2 | -20.3 | 1.6 | 5.1 | 2.8 | 5.4 | 5.7 | 7.4 | 11.4 | 13.1 | 12.1 | 13.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -12% | 5% | 4% | 3% |
| Operating Profit CAGR | -14% | 15% | 10% | 8% |
| PAT CAGR | -7% | 18% | 17% | 14% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 19% | 47% | 28% | 21% |
| ROE Average | 14% | 17% | 15% | 6% |
| ROCE Average | 15% | 15% | 13% | 9% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 660 | 405 | 424 | 477 | 495 | 546 | 607 | 683 | 803 | 940 | 1065 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 209 | 124 | 100 | 197 | 270 | 224 | 127 | 218 | 357 | 299 | 231 |
| Other Non-Current Liabilities | 109 | 44 | 48 | 33 | 39 | 26 | 62 | 83 | 92 | 135 | 140 |
| Total Current Liabilities | 1459 | 1881 | 1665 | 1801 | 2113 | 2008 | 1200 | 1736 | 1407 | 1057 | 896 |
| Total Liabilities | 2438 | 2453 | 2237 | 2508 | 2918 | 2803 | 1997 | 2721 | 2659 | 2430 | 2333 |
| Fixed Assets | 620 | 643 | 625 | 611 | 613 | 608 | 599 | 573 | 1077 | 1082 | 1021 |
| Other Non-Current Assets | 278 | 23 | 23 | 42 | 62 | 103 | 166 | 338 | 28 | 43 | 107 |
| Total Current Assets | 1541 | 1787 | 1589 | 1855 | 2243 | 2092 | 1232 | 1810 | 1554 | 1305 | 1204 |
| Total Assets | 2438 | 2453 | 2237 | 2508 | 2918 | 2803 | 1997 | 2721 | 2659 | 2430 | 2333 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 6 | 14 | 4 | 59 | 113 | 42 | 213 | 352 | 482 | 330 | 279 |
| Cash Flow from Operating Activities | 613 | -136 | 337 | 33 | -262 | 629 | 962 | -87 | 192 | 496 | 271 |
| Cash Flow from Investing Activities | -55 | -51 | -13 | -40 | -59 | -65 | -121 | -187 | -243 | -82 | -98 |
| Cash Flow from Financing Activities | -550 | 177 | -270 | 60 | 250 | -393 | -702 | 404 | -101 | -464 | -392 |
| Net Cash Inflow / Outflow | 8 | -10 | 55 | 54 | -71 | 171 | 139 | 130 | -152 | -50 | -219 |
| Closing Cash & Cash Equivalent | 14 | 4 | 59 | 113 | 42 | 213 | 352 | 482 | 330 | 279 | 61 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 3.17 | -20.26 | 1.64 | 5.11 | 2.77 | 5.45 | 5.66 | 7.41 | 11.36 | 13.06 | 12.13 |
| CEPS(Rs) | 5.59 | -17.53 | 4.61 | 8.23 | 6.05 | 9.28 | 9.91 | 11.68 | 16.4 | 19.1 | 18.55 |
| DPS(Rs) | 0.6 | 0 | 0.5 | 1 | 1 | 0.5 | 1 | 1.2 | 1.2 | 1.5 | 1.5 |
| Book NAV/Share(Rs) | 49.21 | 28.98 | 30.65 | 40.27 | 41.78 | 46.03 | 51.24 | 57.63 | 67.77 | 79.29 | 89.83 |
| Core EBITDA Margin(%) | 6.25 | 3.38 | 6.06 | 5.51 | 5.99 | 7.24 | 9.04 | 7.17 | 8.32 | 9.62 | 9.54 |
| EBIT Margin(%) | 5.59 | -4.47 | 5.87 | 5.76 | 5.14 | 6.45 | 8.26 | 6.27 | 7.54 | 8.85 | 8.37 |
| Pre Tax Margin(%) | 0.71 | -8.32 | 1.21 | 2.71 | 1.6 | 2.5 | 4.78 | 4.59 | 4.73 | 6.16 | 6.11 |
| PAT Margin (%) | 1.45 | -8.05 | 0.78 | 2.19 | 1.05 | 2.29 | 3.04 | 2.99 | 3.62 | 3.96 | 4.26 |
| Cash Profit Margin (%) | 2.56 | -6.97 | 2.19 | 3.53 | 2.29 | 3.9 | 5.32 | 4.72 | 5.22 | 5.8 | 6.52 |
| ROA(%) | 1.48 | -9.82 | 0.83 | 2.55 | 1.21 | 2.26 | 2.8 | 3.72 | 5.01 | 6.08 | 6.03 |
| ROE(%) | 6.59 | -51.83 | 5.49 | 14.41 | 6.76 | 12.41 | 11.64 | 13.62 | 18.12 | 17.77 | 14.34 |
| ROCE(%) | 7.68 | -7.8 | 8.89 | 9.35 | 7.95 | 8.54 | 10.36 | 10.54 | 13.4 | 16.78 | 15.08 |
| Receivable days | 28.75 | 44.15 | 126.68 | 160.28 | 160.02 | 194.96 | 161.58 | 73 | 69.77 | 63.62 | 63.04 |
| Inventory Days | 33.55 | 34.72 | 36.06 | 43.31 | 54.46 | 50.82 | 35.33 | 38.02 | 32.91 | 19.14 | 23.92 |
| Payable days | 74.9 | 84.33 | 97.62 | 92.37 | 85.16 | 107.46 | 120.44 | 74.29 | 49.79 | 30.29 | 35.44 |
| PER(x) | 27.4 | 0 | 35.34 | 11.96 | 14.81 | 4.45 | 12.6 | 11.65 | 8.63 | 7.77 | 12.84 |
| Price/Book(x) | 1.76 | 1.39 | 1.89 | 1.52 | 0.98 | 0.53 | 1.39 | 1.5 | 1.45 | 1.28 | 1.73 |
| Dividend Yield(%) | 0.69 | 0 | 0.86 | 1.64 | 2.43 | 2.06 | 1.4 | 1.39 | 1.22 | 1.48 | 0.96 |
| EV/Net Sales(x) | 0.82 | 0.62 | 0.74 | 0.73 | 0.7 | 0.58 | 0.61 | 0.62 | 0.59 | 0.5 | 0.73 |
| EV/Core EBITDA(x) | 12.15 | 16.01 | 10.04 | 10.04 | 10.76 | 6.88 | 5.61 | 7.71 | 6.33 | 4.54 | 6.79 |
| Net Sales Growth(%) | -22.16 | 15.22 | -16.5 | 8.45 | 14.31 | -11.8 | -20.91 | 35.05 | 25.76 | 4.23 | -12.21 |
| EBIT Growth(%) | -26.19 | -192.17 | 209.8 | 8.83 | 1.14 | 12.88 | 0.26 | 0.92 | 52.34 | 23.25 | -18.27 |
| PAT Growth(%) | -47.08 | -739.65 | 108.09 | 212.05 | -45.73 | 96.33 | 3.94 | 30.94 | 53.26 | 14.97 | -7.17 |
| EPS Growth(%) | -47.08 | -739.65 | 108.09 | 212.05 | -45.73 | 96.33 | 3.94 | 30.94 | 53.26 | 14.97 | -7.17 |
| Debt/Equity(x) | 1.9 | 4.03 | 3.31 | 2.86 | 3.46 | 2.76 | 1.42 | 1.96 | 1.69 | 1.08 | 0.68 |
| Current Ratio(x) | 1.06 | 0.95 | 0.95 | 1.03 | 1.06 | 1.04 | 1.03 | 1.04 | 1.1 | 1.23 | 1.34 |
| Quick Ratio(x) | 0.83 | 0.83 | 0.8 | 0.81 | 0.81 | 0.92 | 0.88 | 0.79 | 0.93 | 1.08 | 1.04 |
| Interest Cover(x) | 1.14 | -1.16 | 1.26 | 1.89 | 1.45 | 1.63 | 2.37 | 3.73 | 2.69 | 3.29 | 3.7 |
| Total Debt/Mcap(x) | 1.08 | 2.9 | 1.75 | 1.89 | 3.52 | 5.24 | 1.02 | 1.31 | 1.17 | 0.85 | 0.39 |
| # | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 |
| FII | 0.84 | 1.11 | 1.61 | 1.84 | 1.45 | 1.66 | 2.12 | 2.12 | 3.09 | 3.01 |
| DII | 1.08 | 1.08 | 3.01 | 2.89 | 5.55 | 6.51 | 6.63 | 7.59 | 7.36 | 9.49 |
| Public | 37.46 | 37.19 | 34.76 | 34.64 | 32.37 | 31.2 | 30.63 | 29.66 | 28.92 | 26.88 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 |
| FII | 0.1 | 0.13 | 0.19 | 0.22 | 0.17 | 0.2 | 0.25 | 0.25 | 0.37 | 0.36 |
| DII | 0.13 | 0.13 | 0.36 | 0.34 | 0.66 | 0.77 | 0.79 | 0.9 | 0.87 | 1.12 |
| Public | 4.44 | 4.41 | 4.12 | 4.11 | 3.84 | 3.7 | 3.63 | 3.51 | 3.43 | 3.19 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 |
| # | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 | 60.63 |
| FII | 0.84 | 1.11 | 1.61 | 1.84 | 1.45 | 1.66 | 2.12 | 2.12 | 3.09 | 3.01 |
| DII | 1.08 | 1.08 | 3.01 | 2.89 | 5.55 | 6.51 | 6.63 | 7.59 | 7.36 | 9.49 |
| Public | 39.37 | 39.37 | 39.37 | 39.37 | 39.37 | 39.37 | 39.37 | 39.37 | 39.37 | 39.37 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 |
| FII | 0.1 | 0.13 | 0.19 | 0.22 | 0.17 | 0.2 | 0.25 | 0.25 | 0.37 | 0.36 |
| DII | 0.13 | 0.13 | 0.36 | 0.34 | 0.66 | 0.77 | 0.79 | 0.9 | 0.87 | 1.12 |
| Public | 4.67 | 4.67 | 4.67 | 4.67 | 4.67 | 4.67 | 4.67 | 4.67 | 4.67 | 4.67 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 | 11.85 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -12% | +5% | +4% | +3% |
| Operating Profit CAGR | -14% | +15% | +10% | +8% |
| PAT CAGR | -7% | +18% | +17% | +14% |
| Share Price CAGR | +19% | +47% | +28% | +21% |
| ROE Average | +14% | +17% | +15% | +6% |
| ROCE Average | +15% | +15% | +13% | +9% |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.